Teflon placement in brain surgery may affect pain return
NCT ID NCT07046247
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 150 patients who had surgery for trigeminal neuralgia, a condition causing severe facial pain. Surgeons used a Teflon implant to cushion a blood vessel pressing on a nerve. The study compared two ways of placing the Teflon—either directly against the nerve or slightly away from it—to see which method better prevents pain from coming back. The goal is to find the safest and most effective technique.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Teflon implant
- What this could lead to
- If successful, this could help surgeons place Teflon in a way that reduces the chance of pain returning after trigeminal neuralgia surgery.
- What could go wrong
- This is a retrospective study, meaning it looks back at past data, so it cannot prove cause and effect. The results may not apply to all patients or guarantee better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
150 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with Trigeminal Neuralgia treated with microvascular decompression
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Trigeminal Neuralgia refractory to medical therapy and treated via microvascular decompression Exclusion Criteria: * Other craniofacial neuralgias, atypical facial pain, trigeminal neuralgia (TN) due to non-vascular causes (e.g., multiple sclerosis), and those with posterior fossa pathology, such as tumors, infarctions, hematomas, infections, or inflammatory lesions * Patients treated by alternative methods, including percutaneous radiofrequency thermocoagulation, glycerol injection, balloon compression, or radiosurgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Microvascular decompression are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Consorcio Hospital General Universitario de Valencia
Valencia, Valencia, 46015, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an IV Anti-Seizure drug calm the lightning bolts of trigeminal neuralgia?
- Surgery targets hidden nerve tethering in trigeminal neuralgia
- Can freezing a nerve silence the 'Suicide Disease'?
- Pain relief showdown: one drug vs. two for facial nerve pain
- New combo therapy aims to calm face pain attacks
- Laser showdown: which light therapy zaps facial pain best?